Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	extracellular matrix structural constituent	COL6A1 COL11A2 COL12A1 LAMB3 LTBP2 ECM1	8.76e-05	188	77	6	GO:0005201
GeneOntologyMolecularFunction	actin binding	MYOT HDAC6 MAP1S MICALL2 MYO5B MYO6 PLEKHH2 TNS1 PALLD	9.27e-05	479	77	9	GO:0003779
GeneOntologyMolecularFunction	lysine-acetylated histone binding	BAZ2A BRD4 TRIM24	2.08e-04	30	77	3	GO:0070577
GeneOntologyMolecularFunction	acetylation-dependent protein binding	BAZ2A BRD4 TRIM24	2.29e-04	31	77	3	GO:0140033
GeneOntologyMolecularFunction	actinin binding	MYOT MICALL2 PALLD	6.09e-04	43	77	3	GO:0042805
GeneOntologyMolecularFunction	molecular adaptor activity	DAB2IP TRIM11 COL11A2 BAZ2A BRD4 GAB4 VAMP2 NCOA1 IRS1 TRIM24 SPEN ADAM10 PCM1 SCAI	6.13e-04	1356	77	14	GO:0060090
GeneOntologyMolecularFunction	extracellular matrix structural constituent conferring tensile strength	COL6A1 COL11A2 COL12A1	7.43e-04	46	77	3	GO:0030020
GeneOntologyMolecularFunction	axon guidance receptor activity	MYOT PALLD	1.11e-03	13	77	2	GO:0008046
GeneOntologyBiologicalProcess	supramolecular fiber organization	COL6A1 COL11A2 COL12A1 CARMIL2 HDAC6 MAP1S KASH5 MICALL2 MYO5B MYO6 LTBP2 PLEKHH2 NCKAP5L PCM1	1.25e-05	957	78	14	GO:0097435
HumanPheno	Congenital muscular torticollis	COL6A1 COL12A1 SYNGAP1	1.36e-05	8	33	3	HP:0005988
Domain	DUF3498	DAB2IP SYNGAP1	5.02e-05	3	77	2	IPR021887
Domain	DUF3498	DAB2IP SYNGAP1	5.02e-05	3	77	2	PF12004
Domain	Bromodomain_CS	BAZ2A BRD4 TRIM24	1.64e-04	26	77	3	IPR018359
Domain	BROMODOMAIN_1	BAZ2A BRD4 TRIM24	4.73e-04	37	77	3	PS00633
Domain	Myosin_head_motor_dom	MYO15B MYO5B MYO6	5.12e-04	38	77	3	IPR001609
Domain	Bromodomain	BAZ2A BRD4 TRIM24	5.12e-04	38	77	3	PF00439
Domain	MYOSIN_MOTOR	MYO15B MYO5B MYO6	5.12e-04	38	77	3	PS51456
Domain	Myosin_head	MYO15B MYO5B MYO6	5.12e-04	38	77	3	PF00063
Domain	MYSc	MYO15B MYO5B MYO6	5.12e-04	38	77	3	SM00242
Domain	MYTH4	MYO15B PLEKHH2	5.93e-04	9	77	2	PS51016
Domain	MyTH4_dom	MYO15B PLEKHH2	5.93e-04	9	77	2	IPR000857
Domain	MyTH4	MYO15B PLEKHH2	5.93e-04	9	77	2	PF00784
Domain	MyTH4	MYO15B PLEKHH2	5.93e-04	9	77	2	SM00139
Domain	BROMODOMAIN_2	BAZ2A BRD4 TRIM24	6.42e-04	41	77	3	PS50014
Domain	BROMO	BAZ2A BRD4 TRIM24	6.89e-04	42	77	3	SM00297
Domain	Bromodomain	BAZ2A BRD4 TRIM24	6.89e-04	42	77	3	IPR001487
Domain	-	BAZ2A BRD4 TRIM24	6.89e-04	42	77	3	1.20.920.10
Domain	Ig_I-set	CHL1 MYOT SPEG NRG2 PALLD	1.13e-03	190	77	5	IPR013098
Domain	I-set	CHL1 MYOT SPEG NRG2 PALLD	1.13e-03	190	77	5	PF07679
Domain	RasGAP	DAB2IP SYNGAP1	1.48e-03	14	77	2	SM00323
Domain	RasGAP_CS	DAB2IP SYNGAP1	1.48e-03	14	77	2	IPR023152
Domain	RasGAP	DAB2IP SYNGAP1	1.70e-03	15	77	2	PF00616
Domain	RAS_GTPASE_ACTIV_1	DAB2IP SYNGAP1	1.70e-03	15	77	2	PS00509
Domain	RAS_GTPASE_ACTIV_2	DAB2IP SYNGAP1	1.70e-03	15	77	2	PS50018
Domain	Laminin_G	COL11A2 COL12A1 SLIT1	1.77e-03	58	77	3	IPR001791
Domain	PH_dom-like	DAB2IP GAB4 IRS1 PLEKHH2 WDFY4 TNS1 SYNGAP1	1.86e-03	426	77	7	IPR011993
Domain	-	DAB2IP SYNGAP1	1.94e-03	16	77	2	1.10.506.10
Domain	ConA-like_dom	TRIM11 COL11A2 COL12A1 SLIT1 TRIM7	2.11e-03	219	77	5	IPR013320
Domain	RasGAP_dom	DAB2IP SYNGAP1	2.46e-03	18	77	2	IPR001936
Domain	IGc2	CHL1 MYOT SPEG NRG2 PALLD	2.86e-03	235	77	5	SM00408
Domain	Ig_sub2	CHL1 MYOT SPEG NRG2 PALLD	2.86e-03	235	77	5	IPR003598
Domain	BBOX	TRIM11 TRIM24 TRIM7	2.90e-03	69	77	3	SM00336
Domain	-	TRIM11 TRIM24 TRIM7	3.15e-03	71	77	3	4.10.45.10
Domain	zf-B_box	TRIM11 TRIM24 TRIM7	3.28e-03	72	77	3	PF00643
Domain	TSPN	COL11A2 COL12A1	4.01e-03	23	77	2	SM00210
Domain	EGF_1	SLIT1 NRG2 LAMB3 LTBP2 PEAR1	4.05e-03	255	77	5	PS00022
Domain	ZF_BBOX	TRIM11 TRIM24 TRIM7	4.41e-03	80	77	3	PS50119
Domain	EGF-like_CS	SLIT1 NRG2 LAMB3 LTBP2 PEAR1	4.47e-03	261	77	5	IPR013032
Domain	Znf_B-box	TRIM11 TRIM24 TRIM7	4.56e-03	81	77	3	IPR000315
Domain	Znf_RING_CS	TRIM11 BARD1 TRIM24 TRIM7	4.62e-03	163	77	4	IPR017907
Domain	EGF_2	SLIT1 NRG2 LAMB3 LTBP2 PEAR1	4.77e-03	265	77	5	PS01186
Domain	Collagen	COL6A1 COL11A2 COL12A1	5.22e-03	85	77	3	IPR008160
Domain	Collagen	COL6A1 COL11A2 COL12A1	5.22e-03	85	77	3	PF01391
Domain	-	DAB2IP GAB4 IRS1 PLEKHH2 TNS1 SYNGAP1	5.51e-03	391	77	6	2.30.29.30
Domain	PH	DAB2IP GAB4 IRS1 PLEKHH2 SYNGAP1	5.82e-03	278	77	5	SM00233
Domain	PH_DOMAIN	DAB2IP GAB4 IRS1 PLEKHH2 SYNGAP1	5.91e-03	279	77	5	PS50003
Domain	PH_domain	DAB2IP GAB4 IRS1 PLEKHH2 SYNGAP1	6.00e-03	280	77	5	IPR001849
Domain	IQ_motif_EF-hand-BS	MYO15B MYO5B MYO6	6.12e-03	90	77	3	IPR000048
Domain	IQ	MYO15B MYO5B MYO6	6.70e-03	93	77	3	PS50096
Domain	-	COL11A2 COL12A1 SLIT1	7.11e-03	95	77	3	2.60.120.200
Pathway	REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES	COL6A1 COL11A2 COL12A1 LAMB3	6.30e-05	61	50	4	M27103
Pathway	REACTOME_COLLAGEN_DEGRADATION	COL6A1 COL11A2 COL12A1 ADAM10	7.61e-05	64	50	4	M26953
Pathway	REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX	COL6A1 COL11A2 COL12A1 LAMB3 ADAM10	1.33e-04	140	50	5	M587
Pathway	PID_AVB3_INTEGRIN_PATHWAY	COL6A1 COL11A2 COL12A1 IRS1	1.34e-04	74	50	4	M160
Pathway	REACTOME_COLLAGEN_FORMATION	COL6A1 COL11A2 COL12A1 LAMB3	2.86e-04	90	50	4	M631
Pathway	REACTOME_COLLAGEN_CHAIN_TRIMERIZATION	COL6A1 COL11A2 COL12A1	4.07e-04	41	50	3	MM15538
Pathway	REACTOME_COLLAGEN_CHAIN_TRIMERIZATION	COL6A1 COL11A2 COL12A1	5.02e-04	44	50	3	M27812
Pathway	REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES	COL6A1 COL11A2 RAB4B NRG2 LAMB3 IRS1 ADAM10 MEF2D	5.18e-04	532	50	8	M27870
Pathway	PID_SYNDECAN_1_PATHWAY	COL6A1 COL11A2 COL12A1	5.72e-04	46	50	3	M198
Pathway	REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION	COL6A1 COL11A2 COL12A1 LAMB3 LTBP2 ADAM10	6.39e-04	300	50	6	M610
Pathway	REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX	COL6A1 COL11A2 COL12A1 ADAM10	7.01e-04	114	50	4	MM14571
Pathway	REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES	COL6A1 COL11A2 COL12A1	7.32e-04	50	50	3	MM14796
Pathway	REACTOME_COLLAGEN_DEGRADATION	COL6A1 COL11A2 COL12A1	8.68e-04	53	50	3	MM14566
Pubmed	The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.	COL6A1 COL12A1 LAMB3 LTBP2 ECM1 ADAM10	2.51e-06	167	80	6	22159717
Pubmed	Novel gene function revealed by mouse mutagenesis screens for models of age-related disease.	MYO6 VAMP2 IRS1 TRIM24	3.28e-06	44	80	4	27534441
Pubmed	Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.	COL6A1 COL11A2 COL12A1 LTBP2 ECM1 ADAM10	3.29e-06	175	80	6	28071719
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	NCKAP5L TRIM24 SPEN PALLD MEF2D PCM1	4.39e-06	184	80	6	32908313
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	CARMIL2 MTUS1 BRD4 IRS1 SIK3 DYRK4 NCKAP5L DENND1A PALLD MEF2D PCM1	4.44e-06	861	80	11	36931259
Pubmed	Cloning and characterization of myr 6, an unconventional myosin of the dilute/myosin-V family.	MYO5B MYO6	5.23e-06	2	80	2	8855265
Pubmed	H19 inhibition increases HDAC6 and regulates IRS1 levels and insulin signaling in the skeletal muscle during diabetes.	HDAC6 IRS1	5.23e-06	2	80	2	35842608
Pubmed	Collagens VI and XII form complexes mediating osteoblast interactions during osteogenesis.	COL6A1 COL12A1	5.23e-06	2	80	2	26753503
Pubmed	Novel defects in collagen XII and VI expand the mixed myopathy/Ehlers-Danlos syndrome spectrum and lead to variant-specific alterations in the extracellular matrix.	COL6A1 COL12A1	5.23e-06	2	80	2	31273343
Pubmed	Protocadherin-12 cleavage is a regulated process mediated by ADAM10 protein: evidence of shedding up-regulation in pre-eclampsia.	PCDH12 ADAM10	5.23e-06	2	80	2	21402705
Pubmed	α-secretase ADAM10 physically interacts with β-secretase BACE1 in neurons and regulates CHL1 proteolysis.	CHL1 ADAM10	1.57e-05	3	80	2	29325091
Pubmed	The temporal and spatial expression pattern of myosin Va, Vb and VI in the mouse ovary.	MYO5B MYO6	1.57e-05	3	80	2	16713372
Pubmed	No association between COL3A1, COL6A1 or COL12A1 gene variants and range of motion.	COL6A1 COL12A1	1.57e-05	3	80	2	23013106
Pubmed	The transcriptional coactivators p/CIP and SRC-1 control insulin resistance through IRS1 in obesity models.	NCOA1 IRS1	1.57e-05	3	80	2	22859932
Pubmed	Proteolytic Processing of Neuregulin 2.	NRG2 ADAM10	1.57e-05	3	80	2	31838721
Pubmed	ECM1 interacts with fibulin-3 and the beta 3 chain of laminin 332 through its serum albumin subdomain-like 2 domain.	LAMB3 ECM1	1.57e-05	3	80	2	19275936
Pubmed	ERp57 is essential for efficient folding of glycoproteins sharing common structural domains.	COL6A1 LAMB3 ADAM10	2.60e-05	25	80	3	17170699
Pubmed	Association of type XI collagen genes with chronic Achilles tendinopathy in independent populations from South Africa and Australia.	COL11A2 COL12A1	3.13e-05	4	80	2	23624467
Pubmed	Crucial role of the H11-H12 loop in stabilizing the active conformation of the human mineralocorticoid receptor.	NCOA1 TRIM24	3.13e-05	4	80	2	10935545
Pubmed	PCM1 recruits Plk1 to the pericentriolar matrix to promote primary cilia disassembly before mitotic entry.	HDAC6 PCM1	3.13e-05	4	80	2	23345402
Pubmed	Interactions between collagen gene variants and risk of anterior cruciate ligament rupture.	COL6A1 COL12A1	3.13e-05	4	80	2	25073002
Pubmed	Ectodomain shedding of the neural recognition molecule CHL1 by the metalloprotease-disintegrin ADAM8 promotes neurite outgrowth and suppresses neuronal cell death.	CHL1 ADAM10	3.13e-05	4	80	2	14761956
Pubmed	Targeted next-generation sequencing reveals multiple deleterious variants in OPLL-associated genes.	COL6A1 COL11A2	3.13e-05	4	80	2	27246988
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	DAB2IP MAP1S SPEG BRD4 USP40 LAMB3 IRS1 TEP1 SPEN DENND1A TRIM7	4.48e-05	1105	80	11	35748872
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	HDAC6 MTUS1 BAZ2A FAM120C BRD4 SIK3 TEP1 CMAS NCKAP5L TRIM24 PCM1	4.89e-05	1116	80	11	31753913
Pubmed	Annexin A2 mediates secretion of collagen VI, pulmonary elasticity and apoptosis of bronchial epithelial cells.	COL6A1 VAMP2	5.20e-05	5	80	2	24357721
Pubmed	Regulation of endodermal differentiation of human embryonic stem cells through integrin-ECM interactions.	COL6A1 COL12A1 LAMB3	5.54e-05	32	80	3	23154389
Pubmed	HDAC6 and Ubp-M BUZ domains recognize specific C-terminal sequences of proteins.	HDAC6 FBXO11	7.79e-05	6	80	2	21090589
Pubmed	Muskelin Coordinates PrPC Lysosome versus Exosome Targeting and Impacts Prion Disease Progression.	MYO6 ADAM10	7.79e-05	6	80	2	30174115
Pubmed	Mechanistic aspects of estrogen receptor activation probed with constitutively active estrogen receptors: correlations with DNA and coregulator interactions and receptor conformational changes.	NCOA1 TRIM24	7.79e-05	6	80	2	9259327
Pubmed	Trip6 promotes dendritic morphogenesis through dephosphorylated GRIP1-dependent myosin VI and F-actin organization.	MYO5B MYO6	7.79e-05	6	80	2	25673849
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	CARMIL2 MAP1S MYO5B MYO6 FAM120C VAMP2 CMAS TNS1 PCM1 SCAI LRCH3 SYNGAP1	1.02e-04	1431	80	12	37142655
Pubmed	A protein interaction landscape of breast cancer.	MYO5B MYO6 LENG1 BARD1 LAMB3 IRS1 CMAS PCM1	1.07e-04	634	80	8	34591612
Pubmed	The tripartite motif family identifies cell compartments.	TRIM11 TRIM24 TRIM7	1.17e-04	41	80	3	11331580
Pubmed	Accumulation of NCOA1 dependent on HERC3 deficiency transactivates matrix metallopeptidases and promotes extracellular matrix degradation in intervertebral disc degeneration.	BRD4 NCOA1 MEF2D	1.35e-04	43	80	3	36878279
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MYO15B MYO5B MYO6 PLEKHH2 WDFY4 PALLD CSTF2T	1.43e-04	493	80	7	15368895
Pubmed	Slit/Robo signaling mediates spatial positioning of spiral ganglion neurons during development of cochlear innervation.	MYO6 SLIT1	1.45e-04	8	80	2	23884932
Pubmed	Different classes of coactivators recognize distinct but overlapping binding sites on the estrogen receptor ligand binding domain.	NCOA1 TRIM24	1.45e-04	8	80	2	9774463
Pubmed	A new role for the architecture of microvillar actin bundles in apical retention of membrane proteins.	MYO15B MYO5B MYO6	1.55e-04	45	80	3	22114352
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	DAB2IP CHMP7 HDAC6 SPEN PALLD MEF2D PCM1	1.62e-04	503	80	7	16964243
Pubmed	BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates.	CLPP MAP1S PLEKHH2 CSTF2T PCM1	1.79e-04	226	80	5	25900982
Pubmed	The MYO6 interactome reveals adaptor complexes coordinating early endosome and cytoskeletal dynamics.	MYO6 FAM120C PCM1 LRCH3	2.04e-04	125	80	4	29467281
Pubmed	Natural helix 9 mutants of PPARγ differently affect its transcriptional activity.	NCOA1 TRIM24	2.32e-04	10	80	2	30595551
Pubmed	A BBSome subunit links ciliogenesis, microtubule stability, and acetylation.	HDAC6 PCM1	2.32e-04	10	80	2	19081074
Pubmed	Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c.	COL6A1 COL12A1 LTBP2 ECM1 ADAM10	2.75e-04	248	80	5	24006456
Pubmed	Tomosyn interacts with the t-SNAREs syntaxin4 and SNAP23 and plays a role in insulin-stimulated GLUT4 translocation.	VAMP2 IRS1	2.84e-04	11	80	2	12832401
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	MYO15B MTUS1 GOLGA2P5 DUOX2 ADAM10 TNS1 PCM1	2.85e-04	552	80	7	10737800
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DAB2IP BAZ2A SPEG SLIT1 SPEN PDZD2	3.59e-04	407	80	6	12693553
Pubmed	Extracellular matrix remodelling in response to venous hypertension: proteomics of human varicose veins.	COL6A1 COL12A1 LTBP2 ECM1	3.68e-04	146	80	4	27068509
Pubmed	Genomic structure and chromosomal mapping of the murine and human Mbd1, Mbd2, Mbd3, and Mbd4 genes.	COL6A1 MYO5B	4.01e-04	13	80	2	10441743
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	HDAC6 MAP1S BAZ2A BRD4 SPEN MEF2D CSTF2T PCM1	4.10e-04	774	80	8	15302935
Pubmed	Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver.	COL6A1 COL12A1 LAMB3 ECM1	4.39e-04	153	80	4	25037231
Pubmed	MED25 is distinct from TRAP220/MED1 in cooperating with CBP for retinoid receptor activation.	MED25 NCOA1	4.67e-04	14	80	2	17641689
Pubmed	Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres.	NCOA1 TRIM24	4.67e-04	14	80	2	11500849
Pubmed	Identification and overlapping expression of multiple unconventional myosin genes in vertebrate cell types.	MYO5B MYO6	4.67e-04	14	80	2	8022818
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	CENPT BAZ2A BRD4 BARD1 CMAS TRIM24 SPEN	5.08e-04	608	80	7	36089195
Pubmed	Annotation and analysis of 10,000 expressed sequence tags from developing mouse eye and adult retina.	NCOA1 ADAM10	5.38e-04	15	80	2	14519200
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	HDAC6 MAP1S NCKAP5L DENND1A PCM1 LRCH3	5.80e-04	446	80	6	24255178
Pubmed	Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells.	HDAC6 NCOA1	6.14e-04	16	80	2	15831516
Pubmed	Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.	CHL1 WDFY4	6.95e-04	17	80	2	22041458
Pubmed	Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination.	BAZ2A BRD4 TRIM24	7.02e-04	75	80	3	25593309
Pubmed	Severe acute respiratory syndrome coronavirus nonstructural protein 2 interacts with a host protein complex involved in mitochondrial biogenesis and intracellular signaling.	SPEN PCM1	7.81e-04	18	80	2	19640993
Pubmed	Proteomic analysis reveals novel ligands and substrates for LNX1 E3 ubiquitin ligase.	FBXO11 PCM1 SYNGAP1	8.17e-04	79	80	3	29121065
Pubmed	T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities.	NCOA1 TRIM24	9.66e-04	20	80	2	11877444
Pubmed	Odd skipped-related 1 identifies a population of embryonic fibro-adipogenic progenitors regulating myogenesis during limb development.	COL6A1 COL12A1	9.66e-04	20	80	2	29084951
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	HDAC6 BAZ2A BRD4 LTBP2 SPEN	9.89e-04	329	80	5	17474147
Pubmed	Comprehensive proteomic characterization of stem cell-derived extracellular matrices.	COL6A1 COL12A1 LTBP2	1.05e-03	86	80	3	28327460
Pubmed	Regulation of skeletal muscle sarcomere integrity and postnatal muscle function by Mef2c.	MYOT MEF2D	1.07e-03	21	80	2	17875930
Pubmed	Agrin has a pathological role in the progression of oral cancer.	COL6A1 TRIM11 MYOT MAP1S	1.13e-03	197	80	4	29872149
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	DAB2IP VAMP2 NRG2 PCM1 SYNGAP1	1.25e-03	347	80	5	17114649
Pubmed	Klf14 is an imprinted transcription factor that regulates placental growth.	LTBP2 PCDH12	1.28e-03	23	80	2	31675530
Pubmed	Matrix-screening reveals a vast potential for direct protein-protein interactions among RNA binding proteins.	HDAC6 MYO6 BRD4 LENG1 DENND1A CSTF2T PCM1	1.39e-03	723	80	7	34133714
Pubmed	Loss of Krox20 results in aortic valve regurgitation and impaired transcriptional activation of fibrillar collagen genes.	COL6A1 COL12A1	1.40e-03	24	80	2	25344368
Pubmed	Nell1-deficient mice have reduced expression of extracellular matrix proteins causing cranial and vertebral defects.	COL6A1 COL11A2 COL12A1 LAMB3	1.43e-03	210	80	4	16537572
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	PRAM1 CENPT BAZ2A BRD4 TRIM24 SPEN MEF2D PCM1	1.58e-03	954	80	8	36373674
Pubmed	The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis.	MICALL2 NCKAP5L PCM1 SYNGAP1	1.64e-03	218	80	4	33378226
Pubmed	Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins.	LAMB3 ECM1	1.64e-03	26	80	2	24742657
Pubmed	Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	NCKAP5L WDFY4 DENND1A	1.66e-03	101	80	3	10997877
Pubmed	Proteomics characterization of extracellular space components in the human aorta.	COL6A1 COL12A1 LTBP2	1.66e-03	101	80	3	20551380
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	BAZ2A BRD4 SPEN PALLD CSTF2T PCM1	1.69e-03	549	80	6	38280479
Pubmed	Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	SIK3 SPEN PALLD	1.71e-03	102	80	3	10231032
Pubmed	Functional genomics identifies therapeutic targets for MYC-driven cancer.	SPEG BRD4 HPS1	1.76e-03	103	80	3	22623531
Pubmed	NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.	BAZ2A BRD4 SPEN	1.76e-03	103	80	3	32744500
Pubmed	Functional interactions between ubiquitin E2 enzymes and TRIM proteins.	TRIM11 TRIM7	1.77e-03	27	80	2	21143188
Pubmed	Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.	COL6A1 MYO5B MYO6 BRD4 SIK3 PCM1 LRCH3	1.77e-03	754	80	7	33060197
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	CLPP COL6A1 HDAC6 FAM120C SPEG BRD4 IRS1 SIK3 ECM1 ADAM10	1.79e-03	1451	80	10	30550785
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	MYO6 BAZ2A PDZD2	1.81e-03	104	80	3	9205841
Pubmed	Basement membrane assembly of the integrin α8β1 ligand nephronectin requires Fraser syndrome-associated proteins.	COL6A1 LAMB3	2.04e-03	29	80	2	22613833
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	CLPP CHMP7 DNAJC4 MYO6 BAZ2A SIK3 CMAS NCKAP5L TRIM24 PCM1	2.15e-03	1487	80	10	33957083
Pubmed	Muscle developmental defects in heterogeneous nuclear Ribonucleoprotein A1 knockout mice.	MYO5B MYO6	2.18e-03	30	80	2	28077597
Pubmed	LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression.	MYO15B HDAC6 MYO5B MYO6 TNS1 LRCH3	2.22e-03	580	80	6	35676659
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	MICALL2 BAZ2A FAM120C MED25 FBXO11 CMAS SPEN DENND1A CSTF2T LRCH3	2.25e-03	1497	80	10	31527615
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	COL6A1 BRD4 NCOA1 NCKAP5L TRIM24	2.28e-03	398	80	5	35016035
Cytoband	Ensembl 112 genes in cytogenetic band chr2q35	SPEG BARD1 TNS1	1.52e-03	129	80	3	chr2q35
Cytoband	Ensembl 112 genes in cytogenetic band chr9q33	DAB2IP DENND1A SCAI	1.84e-03	138	80	3	chr9q33
Cytoband	9q33.3	DENND1A SCAI	1.92e-03	37	80	2	9q33.3
Cytoband	Ensembl 112 genes in cytogenetic band chr8p22	MTUS1 PCM1	3.08e-03	47	80	2	chr8p22
Cytoband	Xq13.1	NHSL2 RTL5	3.21e-03	48	80	2	Xq13.1
Cytoband	1p36.13	SPATA21 SZRD1	4.34e-03	56	80	2	1p36.13
Cytoband	Ensembl 112 genes in cytogenetic band chr19q13	KLK15 ZBTB45 RAB4B KASH5 LENG1 MED25 FAM90A27P	4.80e-03	1192	80	7	chr19q13
Cytoband	11q13.1	EIF1AD SLC22A12	5.47e-03	63	80	2	11q13.1
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	CHL1 MYOT SPEG NRG2 PALLD	9.75e-05	161	52	5	593
GeneFamily	Collagens	COL6A1 COL11A2 COL12A1	3.12e-04	46	52	3	490
GeneFamily	Pleckstrin homology domain containing\|SH2 domain containing\|C2 and RasGAP domain containing	DAB2IP SYNGAP1	3.60e-04	10	52	2	830
GeneFamily	Ring finger proteins\|Tripartite motif containing\|ARF GTPase family	TRIM11 TRIM24 TRIM7	2.58e-03	95	52	3	59
GeneFamily	Ankyrin repeat domain containing\|FERM domain containing	MYO15B PLEKHH2	9.10e-03	50	52	2	1293
Coexpression	GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_DN	CLPP DAB2IP FAM120C BRD4 EIF1AD VAMP2 MEF2D	4.88e-07	155	80	7	M8944
Coexpression	NABA_CORE_MATRISOME	COL6A1 COL11A2 COL12A1 SLIT1 LAMB3 LTBP2 ECM1	1.91e-05	270	80	7	MM17057
Coexpression	LIU_PROSTATE_CANCER_DN	DAB2IP COL6A1 MYO15B NHSL2 SPEG LAMB3 PLEKHH2 TNS1 PALLD	1.95e-05	493	80	9	M19391
Coexpression	NABA_CORE_MATRISOME	COL6A1 COL11A2 COL12A1 SLIT1 LAMB3 LTBP2 ECM1	2.14e-05	275	80	7	M5884
Coexpression	GSE22886_DC_VS_MONOCYTE_UP	COL6A1 MAP1S MICALL2 ECM1 TNS1 PCM1	3.44e-05	200	80	6	M4471
Coexpression	AIZARANI_LIVER_C33_STELLATE_CELLS_2	COL6A1 TNS1 PALLD MEF2D PCM1	4.27e-05	126	80	5	M39132
ToppCell	wk_20-22-Hematologic-Myeloid-GMP\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	PRAM1 MYO15B MICALL2 BRD4 SIK3 DENND1A	5.52e-07	166	80	6	d96e88e73a40205f32cebd7e54ca1ff09ee1e7e8
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL12A1 MYO5B TNS1 PALLD SCAI PDZD2	1.21e-06	190	80	6	30b50d183d7649146eb1e79b47ba897355f1998a
ToppCell	facs-Skin-nan-18m-Epithelial-outer_bulge\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 VAMP2 LTBP2 ECM1 TNS1 PALLD	1.41e-06	195	80	6	ba7cb80deb872c9184769f0dd57855c3c6a432bf
ToppCell	facs-Skin-Telogen-3m-Epithelial-outer_bulge\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 MTUS1 LAMB3 LTBP2 ECM1 TNS1	1.46e-06	196	80	6	c936014125b2ed5f796221b74acb77b8f8359875
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	COL6A1 COL12A1 NHSL2 LTBP2 PLEKHH2 PALLD	1.50e-06	197	80	6	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	10x3'2.3-week_17-19-Mesenchymal_adipo\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	CHL1 COL6A1 COL12A1 LTBP2 PLEKHH2 PALLD	1.50e-06	197	80	6	5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a
ToppCell	10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	CHL1 COL6A1 COL12A1 LTBP2 PLEKHH2 PALLD	1.50e-06	197	80	6	1baffd087ca194a7355fefbb3bf67befb14fe2de
ToppCell	10x3'2.3-week_17-19-Mesenchymal_adipo-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	CHL1 COL6A1 COL12A1 LTBP2 PLEKHH2 PALLD	1.50e-06	197	80	6	b9745e382baa2725dfcae060701fb53f6c8a31fa
ToppCell	NS-critical-d_07-13\|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CHL1 MTUS1 MYO5B MYO6 DUOX2 PALLD	1.54e-06	198	80	6	a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d
ToppCell	10x3'2.3-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CHL1 COL6A1 COL12A1 LTBP2 PLEKHH2 PALLD	1.54e-06	198	80	6	a8c21f4db6730d0aa05b61fbe72bf9f7571a9015
ToppCell	10x3'2.3-week_14-16-Mesenchymal_adipo-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CHL1 COL6A1 COL12A1 LTBP2 PLEKHH2 PALLD	1.54e-06	198	80	6	8b68fc887e5ad0a59ea4d93dfd1edda67030f142
ToppCell	10x3'2.3-week_14-16-Mesenchymal_adipo\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CHL1 COL6A1 COL12A1 LTBP2 PLEKHH2 PALLD	1.54e-06	198	80	6	4739b2e4ab141c66772e61686b45614a1839483e
ToppCell	Epithelial_cells-AT1-AT2_cells\|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id	DAB2IP COL12A1 LAMB3 TNS1 PALLD SCAI	1.54e-06	198	80	6	fbc46b20bcd44f2083170aacbc6f5dd00fba685c
ToppCell	10x5'v1-week_14-16-Mesenchymal_adipo-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CHL1 COL6A1 COL12A1 LTBP2 PLEKHH2 PALLD	1.59e-06	199	80	6	9b2262edbdec89166d895ab97527e0ee5f9b6010
ToppCell	10x5'v1-week_14-16-Mesenchymal_adipo\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CHL1 COL6A1 COL12A1 LTBP2 PLEKHH2 PALLD	1.59e-06	199	80	6	251b3643dcd8f4645b17101bd716e66f12a20e88
ToppCell	10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CHL1 COL6A1 COL12A1 LTBP2 PLEKHH2 PALLD	1.59e-06	199	80	6	6200618e029063486719479c41eaf31798bd13cf
ToppCell	10x5'v1-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CHL1 COL6A1 COL12A1 LTBP2 PLEKHH2 PALLD	1.59e-06	199	80	6	117f4f43b6c06dda553799b1063e827bce697370
ToppCell	367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	COL6A1 COL12A1 LTBP2 PLEKHH2 ECM1 PALLD	1.64e-06	200	80	6	082e718c1da3f4fdd33a001d15ad3ddb2be985c7
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHL1 COL6A1 COL12A1 LTBP2 PLEKHH2 ECM1	1.64e-06	200	80	6	c5d818203bef80ff97c2e0158cf61970673dd258
ToppCell	367C-Fibroblasts-Fibroblast-B_(Myofibroblast)\|367C / Donor, Lineage, Cell class and subclass (all cells)	COL6A1 COL12A1 LTBP2 PLEKHH2 ECM1 PALLD	1.64e-06	200	80	6	731e55070a7ff315091855bd88cda30e5a7e1a98
ToppCell	(5)_Fibroblast-B_(Myofibroblast)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	COL6A1 COL12A1 LTBP2 PLEKHH2 ECM1 PALLD	1.64e-06	200	80	6	9bbaa666d0f3b4782c1b4b95e0fa5fc1467842d8
ToppCell	Adult-Mesenchymal-chondrocyte\|Adult / Lineage, Cell type, age group and donor	COL6A1 NHSL2 LTBP2 PLEKHH2 TNS1	1.00e-05	159	80	5	3f7305ee76447064b5c846c4f576360a2f7e0b7c
ToppCell	facs-Skin-nan-24m-Epithelial-bulge_keratinocyte\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL12A1 LTBP2 ECM1 TNS1 PALLD	1.17e-05	164	80	5	7a65c7a6dbe5fb9067f83efafbb7ec8206d79325
ToppCell	367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	MAP1S BRWD1-AS2 NRG2 LTBP2 TNS1	1.31e-05	168	80	5	2fb2d916eb5000a637240d38e47a9b4f61f9f83f
ToppCell	E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	COL6A1 MYO6 SPATA21 TNS1 PALLD	1.39e-05	170	80	5	7fa022471e14ac8a3bc147c793368a4d56a8e591
ToppCell	TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9\|TCGA-Bladder / Sample_Type by Project: Shred V9	MTUS1 RP1L1 DUOX2 IRS1 SPEN	1.43e-05	171	80	5	adbcfa4bf6bc1c604535a24435924cdb091e2dd7
ToppCell	Control-Epithelial_cells-AT1\|Control / group, cell type (main and fine annotations)	COL12A1 MYO5B TNS1 SCAI PDZD2	1.55e-05	174	80	5	548d7f2b958a2bfd2c95eb049ceaab55a559c77d
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL12A1 LTBP2 PLEKHH2 TNS1 PALLD	1.60e-05	175	80	5	1799a7be623dc3bf53ba580a7c47d2619969d708
ToppCell	COVID-19-Epithelial_cells-AT1\|COVID-19 / group, cell type (main and fine annotations)	MYO5B MYO6 LAMB3 SCAI PDZD2	1.78e-05	179	80	5	a0b33bd69ffdfd5d38d80207fb40058a490aa19e
ToppCell	3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-mLTo\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHL1 COL6A1 IRS1 LTBP2 PALLD	1.83e-05	180	80	5	d1c52aeceb3627e3c5fb6cc3af77e0400f9380ab
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A1 COL12A1 SPEG TNS1 PALLD	1.98e-05	183	80	5	667717366cb181b8a04a347e64f0f5a4dfc6ee7f
ToppCell	normal_Lung-Fibroblasts-Myofibroblasts\|normal_Lung / Location, Cell class and cell subclass	COL6A1 COL12A1 APCDD1L IRS1 LTBP2	2.03e-05	184	80	5	0b336489c10e8c3c957795dd845454f03404382b
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL12A1 MYO5B TNS1 SCAI PDZD2	2.03e-05	184	80	5	57c792e6e2fedba25d3350ffe649fd74750b579d
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL12A1 MYO5B TNS1 SCAI PDZD2	2.03e-05	184	80	5	d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCell	10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-myofibroblast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	DAB2IP COL6A1 COL12A1 MYO6 PALLD	2.25e-05	188	80	5	116ca07ee4413dcc0e9e5ac99bfee6ed7b7847c6
ToppCell	Mesenchymal-chondrocyte\|World / Lineage, Cell type, age group and donor	CHL1 COL6A1 COL11A2 IRS1 PLEKHH2	2.25e-05	188	80	5	7b1e3f8a941eaa68e89c562129a92314642eec66
ToppCell	Control-Epithelial_cells\|Control / group, cell type (main and fine annotations)	MTUS1 MYO5B MYO6 SCAI PDZD2	2.25e-05	188	80	5	707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCell	Mesenchymal-myofibroblast_cell\|World / Lineage, Cell type, age group and donor	COL6A1 COL12A1 IRS1 LTBP2 PLEKHH2	2.31e-05	189	80	5	44e37f88137bb249933eb615235b2cf2ae7f3925
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D231\|Adult / Lineage, Cell type, age group and donor	COL12A1 MYO5B PALLD SCAI PDZD2	2.31e-05	189	80	5	5a04cb25f8f0447b2cecdb6c3695029281aca26d
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	COL6A1 NHSL2 LTBP2 PLEKHH2 PALLD	2.37e-05	190	80	5	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	PND07-28-samps-Mesenchymal-Myofibroblast\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	COL6A1 COL12A1 LTBP2 PLEKHH2 ECM1	2.43e-05	191	80	5	9bbafdf316c1fa3a9f1ee30d41dd7158b5c97279
ToppCell	10x5'v1-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL6A1 COL12A1 MYO5B APCDD1L PALLD	2.43e-05	191	80	5	44b1f62fdee03b157fe545f2ae6ff84f8929a8ac
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMB3 LTBP2 NCKAP5L TNS1 PALLD	2.43e-05	191	80	5	2f733d510a4862565a817f59829d8387d7ea26d9
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMB3 LTBP2 NCKAP5L TNS1 PALLD	2.43e-05	191	80	5	8691eba35793e4e90f93d50c2145847ee51289f7
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A1 NHSL2 LTBP2 PLEKHH2 PALLD	2.43e-05	191	80	5	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	MTUS1 MYO5B MYO6 SCAI PDZD2	2.49e-05	192	80	5	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A1 COL12A1 IRS1 LTBP2 PALLD	2.49e-05	192	80	5	67e845e513e76e820f55e2f0d15eb16f2944d05c
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A1 NHSL2 LTBP2 PLEKHH2 PALLD	2.49e-05	192	80	5	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	MTUS1 MYO5B MYO6 SCAI PDZD2	2.49e-05	192	80	5	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-myocytic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHL1 COL6A1 IRS1 TNS1 PALLD	2.55e-05	193	80	5	146e8c148478ab61b1c1dbaf1ee98a8cd4a0ff8a
ToppCell	CF-Epithelial\|CF / Disease state, Lineage and Cell class	MTUS1 MYO5B MYO6 DUOX2 ECM1	2.55e-05	193	80	5	518901c2e36a79c6189cd0d9e6d36dbd4f56a79c
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	COL6A1 COL12A1 LTBP2 PLEKHH2 PALLD	2.55e-05	193	80	5	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	CF-Epithelial-Epithelial_cell\|CF / Disease state, Lineage and Cell class	MTUS1 MYO5B MYO6 DUOX2 ECM1	2.55e-05	193	80	5	4e3dda27c71b7fdac90d081f0d8e9ca3a8ea7820
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A1 COL12A1 IRS1 LTBP2 PALLD	2.55e-05	193	80	5	5de87fc94a6e58899ef4124cf4887ed3ff96163a
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL6A1 NHSL2 PLEKHH2 TNS1 PALLD	2.62e-05	194	80	5	e93de9428c986b8943fc169258847c650cfab0e5
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A1 COL12A1 LTBP2 PLEKHH2 PALLD	2.62e-05	194	80	5	8fae8061b350336299aa81f378e07deadbd55123
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	COL6A1 NHSL2 LTBP2 PLEKHH2 PALLD	2.62e-05	194	80	5	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	LV-02._Fibroblast_II\|LV / Chamber and Cluster_Paper	COL6A1 COL12A1 LTBP2 PLEKHH2 ECM1	2.62e-05	194	80	5	014d2feb5db2a6a35ef759761a41e466e108c3c1
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MTUS1 MYO5B MYO6 SCAI PDZD2	2.62e-05	194	80	5	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A1 COL12A1 LTBP2 PLEKHH2 PALLD	2.62e-05	194	80	5	4d7d24390fdb379f943ddcc70a63f23955e10163
ToppCell	normal_Lung-Epithelial_cells-AT1\|normal_Lung / Location, Cell class and cell subclass	DAB2IP COL12A1 LAMB3 TNS1 SCAI	2.68e-05	195	80	5	569d1ebc5a5aa110a2430b096755ae35354040c4
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell\|Adult / Lineage, Cell type, age group and donor	COL6A1 NHSL2 LTBP2 PLEKHH2 PALLD	2.68e-05	195	80	5	61c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MTUS1 MYO5B MYO6 SCAI PDZD2	2.68e-05	195	80	5	9406866f99555198a9be311fbd65751b70f35446
ToppCell	facs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 MTUS1 LTBP2 ECM1 TNS1	2.75e-05	196	80	5	90edf61116ffcb4f8b6be3d0a05732d59b0a87d5
ToppCell	LPS_IL1RA_TNF\|World / Treatment groups by lineage, cell group, cell type	CHL1 COL6A1 MTUS1 PLEKHH2 TNS1	2.82e-05	197	80	5	0a6550dce156fc81f15b1e7830d331ca50d87d06
ToppCell	10x3'2.3-week_17-19-Endothelial-stroma-sinusoidal_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	MTUS1 MYO6 PCDH12 ECM1 PEAR1	2.82e-05	197	80	5	4e58bbf3ecb30b4c8199adcc04d2eb134d90de56
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A1 COL12A1 LTBP2 PLEKHH2 PALLD	2.82e-05	197	80	5	26475b9e4d6bfc0ae818dea13d139888ed7e92f1
ToppCell	normal_Lung-Fibroblasts-COL13A1+_matrix_FBs\|normal_Lung / Location, Cell class and cell subclass	COL6A1 LTBP2 PLEKHH2 ECM1 PALLD	2.82e-05	197	80	5	6c57ab2efb8363828e24211c4d45e58bb73a9a4d
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A1 COL12A1 LTBP2 PLEKHH2 PALLD	2.82e-05	197	80	5	16758f181ef07c60aee63072e1da9572c5c85414
ToppCell	distal-mesenchymal-Vascular_Smooth_Muscle-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL6A1 COL12A1 LTBP2 ECM1 PALLD	2.82e-05	197	80	5	da653dc7d216e202f390e5ab0245f243e3ed213b
ToppCell	COVID-19-Fibroblasts\|COVID-19 / group, cell type (main and fine annotations)	COL6A1 NHSL2 LTBP2 PLEKHH2 PALLD	2.82e-05	197	80	5	fb847f2277609c31fffcdf49517243ce0684facf
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A1 COL12A1 LTBP2 PLEKHH2 PALLD	2.82e-05	197	80	5	155e63b33302a87393ace699b2f6d73abe9c5763
ToppCell	AT1-AT2_cells\|World / lung cells shred on cell class, cell subclass, sample id	DAB2IP COL12A1 LAMB3 TNS1 SCAI	2.89e-05	198	80	5	a5b3617ea2ed4bffba59edcf6284799c2b3bbb29
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A1 COL12A1 LTBP2 PLEKHH2 PALLD	2.89e-05	198	80	5	a4005a49cf6709b543994ceb51ecd5dc46197fa9
ToppCell	distal-2-mesenchymal-Vascular_Smooth_Muscle\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL6A1 COL12A1 LTBP2 ECM1 PALLD	2.89e-05	198	80	5	ce05ede69c167b2294630709bb0c223483a6ef75
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHL1 COL6A1 COL12A1 PLEKHH2 ECM1	2.89e-05	198	80	5	7582ee9ec8a87ecb094201f1f9191b412f9d2875
ToppCell	background-Hepatic_Stellate_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	COL6A1 COL12A1 LTBP2 PLEKHH2 ECM1	2.89e-05	198	80	5	bd11b0e9e80449aab979a02c1023e0638c431c7c
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CHL1 NRG2 LAMB3 IRS1 TRIM7	2.89e-05	198	80	5	fc00cb25cdc6c31b7f9d397bc9f9a8f4e9708003
ToppCell	proximal-mesenchymal-Alveolar_Fibroblast\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL6A1 LTBP2 PLEKHH2 ECM1 PALLD	2.96e-05	199	80	5	7f4840ae6a888380feca722543e5e52783f3e35d
ToppCell	Bronchial-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MTUS1 MYO5B MYO6 SCAI PDZD2	2.96e-05	199	80	5	5f7da3eab58ace6cddb3179a415cd839d5767958
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MTUS1 MYO5B MYO6 SCAI PDZD2	2.96e-05	199	80	5	8587bd98de7767a575088afbea07a1feb4516b9b
ToppCell	proximal-3-mesenchymal-Alveolar_Fibroblast\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL6A1 LTBP2 PLEKHH2 ECM1 PALLD	2.96e-05	199	80	5	301d02bbb37e6f1d24b6e865bc3fe3e91260eb30
ToppCell	Parenchymal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MTUS1 MYO5B MYO6 SCAI PDZD2	2.96e-05	199	80	5	5cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A1 COL12A1 APCDD1L LTBP2 ECM1	2.96e-05	199	80	5	9672230aa0bc6a7289050c955f5154ca183a5159
ToppCell	medial-2-mesenchymal-Myofibroblast\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL6A1 SPEG LTBP2 PLEKHH2 PALLD	2.96e-05	199	80	5	95aae608fa35a9c82b12c6f18937ce636750ca44
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A1 COL12A1 APCDD1L LTBP2 ECM1	2.96e-05	199	80	5	e18abe678da293bd01fae55e2f9ab6fdd643d02d
ToppCell	saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MTUS1 MYO5B MYO6 DUOX2 ECM1	2.96e-05	199	80	5	a8f4bd0e65f36b29535864fae4347369d5c864d2
ToppCell	proximal-mesenchymal-Alveolar_Fibroblast-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL6A1 LTBP2 PLEKHH2 ECM1 PALLD	2.96e-05	199	80	5	9a16e519fb0651a7c4d8e05b931df4fb3b0eb3d1
ToppCell	(5)_Fibroblast-G\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	COL6A1 SLIT1 LTBP2 PLEKHH2 PALLD	2.96e-05	199	80	5	b4a737575be9f8c65771832dd8cd25328d5dae0d
ToppCell	LPS_only-Mesenchymal_fibroblastic\|LPS_only / Treatment groups by lineage, cell group, cell type	CHL1 COL6A1 MICALL2 PLEKHH2 PALLD	2.96e-05	199	80	5	211c3a08f2d484ab7a3368006767289088f0d957
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL6A1 MTUS1 IRS1 LTBP2 PALLD	2.96e-05	199	80	5	38cfd367ee8c074c11ba54edeb7a001e375e2687
ToppCell	distal-mesenchymal-Alveolar_Fibroblast-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL6A1 LTBP2 PLEKHH2 ECM1 PALLD	2.96e-05	199	80	5	fb23ecce41e31e2cc01814e3c0add756f489561f
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A1 COL12A1 APCDD1L LTBP2 ECM1	2.96e-05	199	80	5	1fd7bbb8727607e6507848602a19bc86882ef2d5
ToppCell	NS-critical-d_07-13-Epithelial\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CHL1 MTUS1 MYO6 DUOX2 PALLD	2.96e-05	199	80	5	b88a81cd2a89f4d27100c96ae4324dcee68daf83
ToppCell	distal-1-mesenchymal-Myofibroblast\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL6A1 COL12A1 LTBP2 ECM1 PALLD	2.96e-05	199	80	5	58c36f5a30c6862b7f5587a0b9bc31da99e43dd5
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	CHL1 COL6A1 PLEKHH2 TNS1 PALLD	2.96e-05	199	80	5	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-squamous_epithelial_cell\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MTUS1 MYO5B MYO6 DUOX2 ECM1	2.96e-05	199	80	5	eacea42e973f073b410f54c0a1b3a7f2dc2b5a29
ToppCell	medial-mesenchymal-Myofibroblast\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL6A1 SPEG LTBP2 PLEKHH2 PALLD	2.96e-05	199	80	5	e25acdb5809aaff631cb06dbe4c7e59549a0bdb9
ToppCell	distal-2-mesenchymal-Airway_Smooth_Muscle\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL6A1 COL12A1 SPEG LTBP2 PALLD	2.96e-05	199	80	5	af226a6c50747dad9ca696463e715913b3ac17c0
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CHL1 COL6A1 MICALL2 PLEKHH2 PALLD	2.96e-05	199	80	5	8b86c69aaf60feff53aa782559cfece7342a23de
Drug	Prostaglandin E1; Down 200; 10uM; PC3; HT_HG-U133A	CENPT BAZ2A VAMP2 MED25 NRG2 PCDH12 TNS1 PCM1	3.66e-07	196	78	8	6571_DN
Drug	Solasodine [126-17-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A	COL6A1 BAZ2A HPS1 VAMP2 TEP1 TNS1 CSTF2T	4.96e-06	196	78	7	3830_DN
Drug	Ethamivan [304-84-7]; Up 200; 18uM; MCF7; HT_HG-U133A	COL6A1 HDAC6 BRD4 HPS1 VAMP2 PCDH12 CSTF2T	5.13e-06	197	78	7	7021_UP
Drug	prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A	DNAJC4 COL6A1 BAZ2A MED25 NRG2 ADAM10 TNS1	5.13e-06	197	78	7	6547_DN
Drug	Piperine [94-62-2]; Up 200; 14uM; HL60; HT_HG-U133A	DNAJC4 MTUS1 HPS1 LTBP2 TEP1 DENND1A SZRD1	5.13e-06	197	78	7	1327_UP
Drug	Bisoprolol fumarate; Down 200; 9uM; HL60; HT_HG-U133A	CHMP7 MICALL2 BAZ2A VAMP2 NCOA1 CSTF2T LRCH3	5.30e-06	198	78	7	1287_DN
Drug	PF-00539758-00 [351321-34-1]; Down 200; 10uM; MCF7; HT_HG-U133A	COL6A1 BAZ2A VAMP2 MED25 NRG2 LTBP2 MEF2D	5.48e-06	199	78	7	6416_DN
Drug	AC1L1X9Z	CLPP TRIM11 SPEN	4.23e-05	20	78	3	CID000002713
Drug	Lobelanidine hydrochloride [6112-86-3]; Down 200; 10.6uM; PC3; HT_HG-U133A	MTUS1 BAZ2A SPEG VAMP2 FBXO11 PCM1	4.87e-05	190	78	6	5080_DN
Drug	Carbarsone [121-59-5]; Down 200; 15.4uM; MCF7; HT_HG-U133A	HDAC6 MTUS1 VAMP2 FBXO11 TEP1 PCM1	5.16e-05	192	78	6	4110_DN
Drug	Zaprinast [37762-06-4]; Down 200; 14.8uM; PC3; HT_HG-U133A	COL6A1 SPEG HPS1 VAMP2 MED25 TRPV6	5.31e-05	193	78	6	6749_DN
Drug	trifluoperazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A	COL6A1 MAP1S BAZ2A NCOA1 TRPV6 CSTF2T	5.31e-05	193	78	6	5584_DN
Drug	Zidovudine, AZT [30516-87-1]; Down 200; 15uM; PC3; HT_HG-U133A	FAM120C VAMP2 MED25 PCDH12 ECM1 TNS1	5.31e-05	193	78	6	6733_DN
Drug	Kawain [500-64-1]; Up 200; 17.4uM; MCF7; HT_HG-U133A	FAM120C SPEG VAMP2 MED25 MEF2D CSTF2T	5.47e-05	194	78	6	2299_UP
Drug	Hemicholinium bromide [312-45-8]; Down 200; 7uM; PC3; HT_HG-U133A	MAP1S HPS1 VAMP2 MED25 TRPV6 PCDH12	5.62e-05	195	78	6	6739_DN
Drug	haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A	BRD4 VAMP2 NRG2 NCOA1 TEP1 DENND1A	5.62e-05	195	78	6	5241_DN
Drug	17-DMAG; Down 200; 0.1uM; HL60; HT_HG-U133A	CHMP7 CENPT BRD4 NCOA1 TNS1 PCM1	5.62e-05	195	78	6	6172_DN
Drug	Acyclovir [59277-89-3]; Down 200; 17.8uM; PC3; HT_HG-U133A	HPS1 DUOX2 TEP1 ECM1 MEF2D PCM1	5.79e-05	196	78	6	4683_DN
Drug	Adamantamine fumarate [80789-67-9]; Up 200; 9.6uM; HL60; HT_HG-U133A	CENPT HPS1 NCOA1 TEP1 TNS1 MEF2D	5.79e-05	196	78	6	1344_UP
Drug	Epicatechin-(-) [154-23-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A	BAZ2A FAM120C VAMP2 TRPV6 CSTF2T PDZD2	5.79e-05	196	78	6	4419_DN
Drug	Alclometasone dipropionate [667634-13-2]; Up 200; 7.6uM; MCF7; HT_HG-U133A	BAZ2A FAM120C BRD4 FBXO11 TEP1 PDZD2	5.79e-05	196	78	6	6229_UP
Drug	haloperidol; Down 200; 10uM; HL60; HT_HG-U133A	MTUS1 BAZ2A BRD4 VAMP2 ECM1 TNS1	5.79e-05	196	78	6	6203_DN
Drug	Ethaverine hydrochloride [985-13-7]; Down 200; 9.2uM; PC3; HT_HG-U133A	MAP1S MTUS1 SPEG NRG2 TRPV6 TNS1	5.95e-05	197	78	6	6737_DN
Drug	Ifosfamide [3778-73-2]; Up 200; 15.4uM; MCF7; HT_HG-U133A	VAMP2 LAMB3 FBXO11 TRPV6 ADAM10 PCM1	5.95e-05	197	78	6	3485_UP
Drug	Arecoline hydrobromide [300-08-3]; Up 200; 17uM; MCF7; HT_HG-U133A	COL6A1 BAZ2A VAMP2 NRG2 LTBP2 PCM1	5.95e-05	197	78	6	2657_UP
Drug	clozapine; Down 200; 10uM; HL60; HT_HG-U133A	COL6A1 MTUS1 VAMP2 MED25 MEF2D PCM1	5.95e-05	197	78	6	2689_DN
Drug	Indoprofen [31842-01-0]; Down 200; 14.2uM; HL60; HT_HG-U133A	BAZ2A BRD4 NRG2 FBXO11 TRPV6 LTBP2	5.95e-05	197	78	6	3007_DN
Drug	5155877; Down 200; 10uM; PC3; HT_HG-U133A	BAZ2A VAMP2 NRG2 PCDH12 CSTF2T PCM1	6.12e-05	198	78	6	6569_DN
Drug	Altretamine [654-05-6]; Down 200; 19uM; PC3; HT_HG-U133A	FAM120C BRD4 HPS1 VAMP2 TRPV6 PCDH12	6.12e-05	198	78	6	4627_DN
Drug	Deferoxamine mesylate [138-14-7]; Up 200; 6uM; MCF7; HT_HG-U133A	FAM120C SPEG MED25 ECM1 MEF2D PCM1	6.12e-05	198	78	6	3842_UP
Drug	Diperodon hydrochloride [537-12-2]; Down 200; 9.2uM; PC3; HT_HG-U133A	COL6A1 BAZ2A VAMP2 MED25 TRPV6 PCM1	6.12e-05	198	78	6	4498_DN
Drug	Cinnarizine [298-57-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A	MAP1S MICALL2 BAZ2A NCOA1 LAMB3 CSTF2T	6.12e-05	198	78	6	3175_DN
Drug	Adiphenine hydrochloride [50-42-0]; Up 200; 11.4uM; PC3; HT_HG-U133A	DNAJC4 MTUS1 BAZ2A BRD4 DYRK4 PCM1	6.12e-05	198	78	6	7279_UP
Drug	Reserpine [50-55-5]; Down 200; 6.6uM; PC3; HT_HG-U133A	COL6A1 CENPT MED25 PCDH12 ADAM10 TNS1	6.12e-05	198	78	6	4203_DN
Drug	Heptaminol hydrochloride [543-15-7]; Down 200; 22uM; PC3; HT_HG-U133A	SPEG VAMP2 MED25 DYRK4 SPEN PCM1	6.12e-05	198	78	6	1825_DN
Drug	Levopropoxyphene napsylate [5714-90-9]; Down 200; 7.4uM; MCF7; HT_HG-U133A	BAZ2A HPS1 VAMP2 LAMB3 MEF2D PCM1	6.29e-05	199	78	6	3543_DN
Drug	Homochlorcyclizine dihydrochloride [1982-36-1]; Down 200; 10.4uM; HL60; HT_HG-U133A	KLK15 MED25 TRPV6 LTBP2 PCDH12 PCM1	6.29e-05	199	78	6	2386_DN
Drug	candesartan cilexetil	COL6A1 COL11A2 COL12A1 MYO5B MYO6	1.42e-04	145	78	5	CID000002540
Drug	GK-101	COL6A1 COL11A2 COL12A1	2.55e-04	36	78	3	CID000161853
Drug	1-alpha-25-dihydroxycholecalciferol	COL6A1 MTUS1 USP40 NRG2 NCOA1 TRPV6 IRS1 TRIM24 ADAM10 PALLD PDZD2	2.61e-04	909	78	11	CID000002524
Drug	Ebna	CHL1 HDAC6 BRD4 TEP1 MEF2D	4.17e-04	183	78	5	CID000018835
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A	COL6A1 MTUS1 VAMP2 IRS1 PALLD	4.72e-04	188	78	5	2208_UP
Drug	Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A	BAZ2A HPS1 SPEN PALLD SZRD1	4.72e-04	188	78	5	4845_DN
Drug	Ampyrone [83-07-8]; Down 200; 19.6uM; PC3; HT_HG-U133A	COL6A1 MTUS1 BAZ2A SPEN LRCH3	4.95e-04	190	78	5	4507_DN
Drug	5707885; Down 200; 50uM; PC3; HT_HG-U133A	MED25 FBXO11 TNS1 MEF2D PCM1	5.07e-04	191	78	5	6390_DN
Drug	Calciferol [50-14-6]; Down 200; 10uM; PC3; HT_HG-U133A	COL6A1 BRD4 HPS1 TEP1 ADAM10	5.07e-04	191	78	5	6746_DN
Drug	Ald1.1-H_000455; Up 200; 10uM; PC3; HT_HG-U133A	DNAJC4 COL6A1 FAM120C NCOA1 TNS1	5.07e-04	191	78	5	7547_UP
Drug	Fenbufen [36330-85-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A	DNAJC4 HPS1 LTBP2 TEP1 PCM1	5.19e-04	192	78	5	4743_DN
Drug	Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A	MTUS1 TEP1 SPEN SZRD1 PCM1	5.19e-04	192	78	5	4104_DN
Drug	AG-013608 [351320-38-2]; Down 200; 10uM; MCF7; HT_HG-U133A	FBXO11 SPEN PALLD MEF2D PCM1	5.19e-04	192	78	5	6435_DN
Drug	Madecassol	COL6A1 COL11A2 COL12A1	5.28e-04	46	78	3	CID000108062
Drug	Idoxuridine [54-42-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A	COL6A1 FAM120C VAMP2 LAMB3 FBXO11	5.32e-04	193	78	5	1480_UP
Drug	Dizocilpine maleate [77086-22-7]; Up 200; 11.8uM; MCF7; HT_HG-U133A	COL6A1 VAMP2 PCDH12 TEP1 CSTF2T	5.32e-04	193	78	5	6223_UP
Drug	AG-013608 [351320-38-2]; Down 200; 10uM; PC3; HT_HG-U133A	COL6A1 HDAC6 PCDH12 ECM1 TNS1	5.32e-04	193	78	5	6400_DN
Drug	thioridazine hydrochloride; Up 200; 10uM; HL60; HT_HG-U133A	COL6A1 VAMP2 MED25 LTBP2 PALLD	5.32e-04	193	78	5	6189_UP
Drug	Carcinine [56897-53-1]; Down 200; 22uM; PC3; HT_HG-U133A	HPS1 VAMP2 MED25 NRG2 NCOA1	5.32e-04	193	78	5	4225_DN
Drug	Eburnamonine (-) [4880-88-0]; Down 200; 13.6uM; MCF7; HT_HG-U133A	BRD4 VAMP2 PCDH12 MEF2D CSTF2T	5.32e-04	193	78	5	6802_DN
Drug	Nimesulide [51803-78-2]; Up 200; 13uM; MCF7; HT_HG-U133A	MED25 TRPV6 TEP1 TNS1 MEF2D	5.32e-04	193	78	5	2275_UP
Drug	PNU-0251126 [267429-19-6]; Down 200; 10uM; PC3; HT_HG-U133A	SPEG BRD4 VAMP2 TEP1 ECM1	5.32e-04	193	78	5	7388_DN
Drug	Captopril [62571-86-2]; Down 200; 17.2uM; MCF7; HT_HG-U133A	VAMP2 TRPV6 LTBP2 MEF2D CSTF2T	5.32e-04	193	78	5	4410_DN
Drug	Acenocoumarol [152-72-7]; Down 200; 11.4uM; MCF7; HT_HG-U133A	COL6A1 HDAC6 HPS1 TEP1 SZRD1	5.32e-04	193	78	5	7232_DN
Drug	Lynestrenol [52-76-6]; Down 200; 14uM; PC3; HT_HG-U133A	COL6A1 MICALL2 MED25 TEP1 CSTF2T	5.44e-04	194	78	5	6756_DN
Drug	Lasalocid sodium salt [25999-20-6]; Down 200; 6.6uM; HL60; HT_HG-U133A	BRD4 MED25 NCOA1 LTBP2 TNS1	5.44e-04	194	78	5	3021_DN
Drug	Nilutamide [63612-50-0]; Up 200; 12.6uM; MCF7; HT_HG-U133A	COL6A1 CENPT BAZ2A HPS1 SPEN	5.44e-04	194	78	5	5362_UP
Drug	Roxarsone [121-19-7]; Down 200; 15.2uM; PC3; HT_HG-U133A	MED25 NRG2 FBXO11 CSTF2T PCM1	5.44e-04	194	78	5	5051_DN
Drug	Hydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; PC3; HT_HG-U133A	COL6A1 VAMP2 MED25 LTBP2 PCM1	5.44e-04	194	78	5	5075_DN
Drug	Bendroflumethiazide [73-48-3]; Down 200; 9.4uM; PC3; HT_HG-U133A	COL6A1 SPEG TNS1 CSTF2T PCM1	5.44e-04	194	78	5	3758_DN
Drug	Methazolamide [554-57-4]; Down 200; 17uM; PC3; HT_HG-U133A	COL6A1 HPS1 VAMP2 NRG2 ECM1	5.44e-04	194	78	5	5794_DN
Drug	Cinchonine [118-10-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A	BAZ2A HPS1 VAMP2 TEP1 SZRD1	5.44e-04	194	78	5	4107_DN
Drug	Lactobionic acid [96-82-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A	CLPP BAZ2A HPS1 NCOA1 DYRK4	5.44e-04	194	78	5	4950_DN
Drug	Galanthamine hydrobromide [1953-04-4]; Down 200; 10.8uM; MCF7; HT_HG-U133A	HDAC6 MTUS1 NCOA1 CMAS SZRD1	5.44e-04	194	78	5	4772_DN
Drug	Nafronyl oxalate [3200-06-4]; Up 200; 8.4uM; HL60; HT_HG-U133A	CENPT VAMP2 TRPV6 TNS1 PCM1	5.44e-04	194	78	5	1267_UP
Drug	Iopanoic acid [96-83-3]; Up 200; 7uM; HL60; HT_HG-U133A	MTUS1 HPS1 LAMB3 TRPV6 TNS1	5.44e-04	194	78	5	2965_UP
Drug	0317956-0000 [391210-11-0]; Down 200; 10uM; PC3; HT_HG-U133A	COL6A1 MTUS1 HPS1 MED25 TNS1	5.44e-04	194	78	5	3774_DN
Drug	Luteolin [491-70-3]; Up 200; 14uM; MCF7; HT_HG-U133A	BAZ2A HPS1 LTBP2 ECM1 DENND1A	5.44e-04	194	78	5	3379_UP
Drug	Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Down 200; 7.6uM; PC3; HT_HG-U133A	COL6A1 VAMP2 MED25 NRG2 TNS1	5.44e-04	194	78	5	4248_DN
Drug	S(-)Eticlopride hydrochloride [97612-24-3]; Down 200; 10.6uM; MCF7; HT_HG-U133A	SPEG TRPV6 MEF2D CSTF2T PCM1	5.57e-04	195	78	5	3393_DN
Drug	Acebutolol hydrochloride [34381-68-5]; Up 200; 10.8uM; PC3; HG-U133A	COL6A1 CENPT BAZ2A SPEG MED25	5.57e-04	195	78	5	1911_UP
Drug	Indapamide [26807-65-8]; Down 200; 10.6uM; PC3; HT_HG-U133A	BAZ2A FAM120C VAMP2 MED25 CSTF2T	5.57e-04	195	78	5	3778_DN
Drug	Talampicillin hydrochloride [39878-70-1]; Up 200; 7.8uM; PC3; HT_HG-U133A	COL6A1 FAM120C TEP1 TNS1 PCM1	5.57e-04	195	78	5	7254_UP
Drug	Isoniazid [54-85-3]; Down 200; 29.2uM; PC3; HT_HG-U133A	MAP1S VAMP2 ECM1 CSTF2T PCM1	5.57e-04	195	78	5	5840_DN
Drug	Homosalate [118-56-9]; Down 200; 15.2uM; PC3; HT_HG-U133A	MAP1S MYO6 FAM120C MED25 TEP1	5.57e-04	195	78	5	4533_DN
Drug	Deoxycorticosterone [64-85-7]; Up 200; 12.2uM; HL60; HT_HG-U133A	COL6A1 MTUS1 BAZ2A FAM120C PCDH12	5.57e-04	195	78	5	3099_UP
Drug	Metrizamide [31112-62-6]; Down 200; 5uM; MCF7; HT_HG-U133A	COL6A1 MICALL2 HPS1 VAMP2 CSTF2T	5.57e-04	195	78	5	4156_DN
Drug	(R)-(+)-Atenolol [56715-13-0]; Up 200; 15uM; MCF7; HT_HG-U133A	HDAC6 MAP1S MTUS1 BRD4 MEF2D	5.57e-04	195	78	5	2855_UP
Drug	N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; PC3; HT_HG-U133A	COL6A1 MTUS1 MED25 TNS1 PCM1	5.57e-04	195	78	5	3755_DN
Drug	Oxprenolol hydrochloride [6452-73-9]; Down 200; 13.2uM; MCF7; HT_HG-U133A	CHMP7 CENPT HDAC6 BRD4 DYRK4	5.57e-04	195	78	5	7225_DN
Drug	Chlortetracycline hydrochloride [64-72-2]; Up 200; 7.8uM; PC3; HT_HG-U133A	HDAC6 MTUS1 HPS1 FBXO11 MEF2D	5.57e-04	195	78	5	6761_UP
Drug	Colchicine [64-86-8]; Down 200; 10uM; PC3; HT_HG-U133A	MTUS1 BAZ2A BRD4 HPS1 CSTF2T	5.57e-04	195	78	5	4614_DN
Drug	Acenocoumarol [152-72-7]; Up 200; 11.4uM; MCF7; HT_HG-U133A	HPS1 NRG2 DUOX2 LTBP2 MEF2D	5.70e-04	196	78	5	2240_UP
Drug	Suxibuzone [27470-51-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A	COL6A1 VAMP2 TRPV6 LTBP2 PCM1	5.70e-04	196	78	5	6065_DN
Drug	Aminohippuric acid [61-78-9]; Down 200; 20.6uM; HL60; HT_HG-U133A	CHMP7 DNAJC4 CENPT MTUS1 BRD4	5.70e-04	196	78	5	3076_DN
Drug	17-AAG; Up 200; 1uM; PC3; HT_HG-U133A	HDAC6 HPS1 MEF2D PCM1 PDZD2	5.70e-04	196	78	5	5919_UP
Drug	Gossypol [303-45-7]; Down 200; 7.8uM; MCF7; HT_HG-U133A	BRD4 HPS1 FBXO11 ADAM10 CSTF2T	5.70e-04	196	78	5	6058_DN
Drug	AG-028671 [847803-03-6]; Down 200; 10uM; PC3; HT_HG-U133A	MICALL2 MYO6 ADAM10 TNS1 PCM1	5.70e-04	196	78	5	6582_DN
Drug	Althiazide [5588-16-9]; Down 200; 10.4uM; PC3; HT_HG-U133A	COL6A1 SPEG MED25 TNS1 MEF2D	5.70e-04	196	78	5	4491_DN
Drug	(-)-Cinchonidine [485-71-2]; Down 200; 13.6uM; PC3; HT_HG-U133A	COL6A1 HDAC6 NRG2 TNS1 PCM1	5.70e-04	196	78	5	5833_DN
Drug	Methoxy-8-psoralen [298-81-7]; Down 200; 18.6uM; MCF7; HT_HG-U133A	BRD4 VAMP2 TEP1 SZRD1 LRCH3	5.70e-04	196	78	5	3302_DN
Drug	Bisoprolol fumarate; Down 200; 9uM; PC3; HT_HG-U133A	COL6A1 HPS1 TRPV6 PCDH12 TNS1	5.70e-04	196	78	5	6748_DN
Drug	Epicatechin-(-) [154-23-4]; Down 200; 13.8uM; PC3; HT_HG-U133A	BAZ2A SPEG TNS1 MEF2D PCM1	5.70e-04	196	78	5	4594_DN
Disease	Bethlem myopathy (is_implicated_in)	COL6A1 COL12A1	4.23e-05	4	79	2	DOID:0050663 (is_implicated_in)
Disease	Ullrich congenital muscular dystrophy	COL6A1 COL12A1	4.23e-05	4	79	2	cv:C4551860
Disease	Bethlem myopathy	COL6A1 COL12A1	4.23e-05	4	79	2	cv:C1834674
Disease	BETHLEM MYOPATHY 1	COL6A1 COL12A1	4.23e-05	4	79	2	C1834674
Disease	Ullrich congenital muscular dystrophy (is_implicated_in)	COL6A1 COL12A1	4.23e-05	4	79	2	DOID:0050558 (is_implicated_in)
Disease	Ullrich congenital muscular dystrophy 1	COL6A1 COL12A1	4.23e-05	4	79	2	C0410179
Disease	Prostatic Neoplasms	DAB2IP RAB4B HDAC6 BAZ2A BRD4 NCOA1 IRS1 SPEN	2.45e-04	616	79	8	C0033578
Disease	Malignant neoplasm of prostate	DAB2IP RAB4B HDAC6 BAZ2A BRD4 NCOA1 IRS1 SPEN	2.45e-04	616	79	8	C0376358
Disease	Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive	CLPP COL11A2 MYO6	3.51e-04	51	79	3	cv:CN043650
Disease	level of Phosphatidylethanolamine (18:1_18:1) in blood serum	SIK3 ADAM10	6.31e-04	14	79	2	OBA_2045142
Disease	Nonsyndromic genetic hearing loss	CLPP COL11A2 MYO6	1.13e-03	76	79	3	cv:C5680182
Disease	level of Phosphatidylethanolamine (16:0_18:2) in blood serum	SIK3 ADAM10	1.88e-03	24	79	2	OBA_2045136
Disease	airway responsiveness measurement	WDFY4 LRCH3	1.88e-03	24	79	2	EFO_0006897

Protein segments in the cluster

Peptide	Gene	Start	Entry
APPPNLTSNRRLQQT	VAMP2	21	P63027
PQTLRQRQHTRPPPQ	BRWD1-AS2	51	P59051
MPDNRQPRNRQPRIR	BARD1	1	Q99728
QPRNRQPRIRSGNEP	BARD1	6	Q99728
LPQQPSRPSNRAAAL	BRD4	866	O60885
KRRRPPQPIQQPQRQ	ADAM10	721	O14672
PQPIQQPQRQRPRES	ADAM10	726	O14672
DRLRTQPFQAQPPQQ	BAZ2A	956	Q9UIF9
PLPLNDVAQAQRSRP	CARMIL2	671	Q6F5E8
VQRRLQPQPRASPRL	APCDD1L	201	Q8NCL9
QLRQPRSAQAVAPQP	RAB4B	196	P61018
QPRRNARPGPVQQDL	QRICH2	186	Q9H0J4
RNASRENLNLPEPQP	PCDH12	856	Q9NPG4
NPPERPARRELQQAL	KASH5	476	Q8N6L0
PRQNSAGPQRRIDQP	DAB2IP	906	Q5VWQ8
SFPAAIQRNQPQRPE	LRCH3	596	Q96II8
LQLRLNPPAQLPNSE	MAP1S	191	Q66K74
PDRNPQNIRVQASQP	CHL1	711	O00533
LSPQLPRNSRIPCRN	NCKAP5L	476	Q9HCH0
PPVSCLRRNSDNRNP	MTUS1	731	Q9ULD2
RNRQTQPELPAEPQL	EIF1AD	116	Q8N9N8
QFNPQLARRPRQQDP	LENG1	246	Q96BZ8
PQLPNPRRLSNAATR	DUOX2	76	Q9NRD8
QRPPRAKNPQEQQRR	FAM90A27P	11	A6NNH2
PLSPAQTNPVVQRRN	MICALL2	151	Q8IY33
NQLRDSQPPAVPDNR	PCM1	351	Q15154
RLVQPARLNPQVRPA	KLK15	111	Q9H2R5
PGSPQALRNPLLRQR	PDZD2	946	O15018
RQPPQFWDSQRRRQP	PEAR1	956	Q5VY43
RPQQQPQPRSPAARR	NRG2	66	O14511
PHRAQRSPQQQPSRL	COL11A2	241	P13942
RSPQQQPSRLHRPQN	COL11A2	246	P13942
ARPSQNLLQLRPPQP	MED25	576	Q71SY5
RPQNPGANPQLRSLL	MED25	636	Q71SY5
PRPRRNLRQQPQPQE	GOLGA2P5	61	Q9HBQ8
SAPQQIINPIRRHPQ	IRS1	641	P35568
KQTRRRQPQNQPGPL	PLEKHH2	1026	Q8IVE3
SRRPQDNRSTPVQPL	PALLD	91	Q8WX93
QPRQRAPTALLQPDA	MYO15B	36	Q96JP2
HQSRNLKPQPRPQTL	DYRK4	401	Q9NR20
RDQLLPPSPNNRIAL	COL6A1	711	P12109
PPNQRRRTLENLIPD	COL12A1	771	Q99715
RRNNVILQPLQPDTP	COL12A1	2076	Q99715
PRRVSRPRPVQQQQQ	FBXO11	11	Q86XK2
NPRNRHFTNSVPNPR	CHMP7	401	Q8WUX9
NPTPPNLRNNRVINE	GAB4	431	Q2WGN9
PLQPQSVQRPGLARR	CENPT	196	Q96BT3
FRNNRLGNPPLPRNQ	FAM120C	421	Q9NX05
LQQERQRLGQRQPPP	DNAJC4	211	Q9NNZ3
PSRAQQSRRVQPPAQ	LTBP2	106	Q14767
PRRPQNRDSILNPSD	DENND1A	671	Q8TEH3
VRCQSLPQRPNARLN	LAMB3	171	Q13751
QQNPPAPQPQHLARR	CSTF2T	231	Q9H0L4
RPSPDNLNQICLPNR	ECM1	171	Q16610
TRQRRSRQNPQSPPQ	HDAC6	11	Q9UBN7
QPSPRRARSSQNIPV	HPS1	256	Q92902
PNQRPHQCRRFRQPQ	SLC22A12	81	Q96S37
PRLLSPQQPALQRNS	MEF2D	176	Q14814
ASPPIIQPSRRRNQN	RTL5	496	Q5HYW3
PEDSRQPNNVIRQPL	SZRD1	126	Q7Z422
RREPDRAQQQPQKPA	SPATA21	56	Q7Z572
QRLCPRNPPQQLAEL	NHSL2	11	Q5HYW2
TEPLNLNPAKRPRRQ	CMAS	191	Q8NFW8
RQTLNRPPAAPNQLR	NCOA1	1041	Q15788
RPPAAPNQLRLQLQQ	NCOA1	1046	Q15788
VQQAARRPPQDPALR	PRAM1	531	Q96QH2
QLQRLRIQPSSPPPN	SIK3	721	Q9Y2K2
QRPPQRTLQNGLALQ	CLPP	31	Q16740
RQQVQRRPAPVGLPN	TRIM24	481	O15164
CRELSPQRNLRPNRP	TRIM11	56	Q96F44
CREPARPSQLRPNRQ	TRIM7	81	Q9C029
RKQRQPARLQLPAPP	ZBTB45	171	Q96K62
PRLLPQQAANQPLDS	TEP1	1621	Q99973
RAPLQPQQIEVRAPQ	SPEN	3121	Q96T58
LQPQLASEAPRRPAQ	SPEG	286	Q15772
QRQPSRQSERPRPQP	SYNGAP1	731	Q96PV0
PGRPQERNPTAQQLR	RP1L1	116	Q8IWN7
QQQQPRPPPRQQERA	TNS1	656	Q9HBL0
TSPRNLQPQRAALAP	WDFY4	1006	Q6ZS81
PLKPRTNNRTSPRDN	TRPV6	391	Q9H1D0
RQPQQPRSRLAPRLT	SCAI	6	Q8N9R8
PRCQNPDFLRQIPLQ	SLIT1	696	O75093
KSQLQRPPEARANPR	USP40	481	Q9NVE5
PIDVQRNQLPFLRNP	MYO5B	51	Q9ULV0
PQQNPAAQIPARQRE	MYO6	1156	Q9UM54
TARPNQTLPAPKQLR	MYOT	441	Q9UBF9